Citius Pharmaceuticals, Inc. - Common Stock (CTXR)
1.0700
-0.3000 (-21.90%)
NASDAQ · Last Trade: Jun 10th, 1:33 PM EDT
Detailed Quote
Previous Close | 1.370 |
---|---|
Open | 1.000 |
Bid | 1.060 |
Ask | 1.080 |
Day's Range | 0.9118 - 1.100 |
52 Week Range | 0.6500 - 26.25 |
Volume | 5,051,964 |
Market Cap | 156.20M |
PE Ratio (TTM) | -0.1861 |
EPS (TTM) | -5.8 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 5,253,788 |
Chart
About Citius Pharmaceuticals, Inc. - Common Stock (CTXR)
Citius Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapeutic products for critical care and cancer treatment. The company primarily specializes in the formulation and commercialization of medical products that aim to address unmet medical needs in the areas of oncology and critical care medicine. Citius is actively engaged in advancing its product pipeline through clinical trials, emphasizing the development of safe and effective therapies to improve patient outcomes. The company's commitment to research and development positions it as a key player in the pharmaceutical landscape, aiming to provide new treatment options for healthcare providers and patients alike. Read More
News & Press Releases
Volume analysis on 2025-06-10: stocks with an unusual volume in today's session.
Via Chartmill · June 10, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · June 10, 2025
Citius announced a $15.8 million direct offering.
Via Benzinga · June 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 10, 2025

Citius Pharmaceuticals shares are trading lower by 15% during Wednesday's session. The company announced a $3 million registered direct offering.
Via Benzinga · January 8, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · June 10, 2025
Via Benzinga · June 10, 2025
Via Benzinga · June 10, 2025
Via Benzinga · June 9, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · June 9, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · June 9, 2025
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares are trading higher Monday after the company announced it entered into a distribution services agreement with Cardinal Health.
Via Benzinga · June 9, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · June 9, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · June 9, 2025
Via Benzinga · May 23, 2025
Via Benzinga · May 14, 2025
Volume analysis on 2025-04-01: stocks with an unusual volume in today's session.
Via Chartmill · April 1, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 31, 2025
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · March 28, 2025

Via Benzinga · January 16, 2025

Via Benzinga · December 30, 2024

U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.
Via Benzinga · December 30, 2024